RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101
Publication date: Available online 21 March 2018 Source:European Journal of Cancer Author(s): Christopher J.D. Wallis, Zachary Klaassen
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου